In the latest quarter, 4 analysts provided ratings for Metagenomi (NASDAQ:MGX), showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $10.75, a high estimate of $15.00, and a low estimate of $7.00. Surpassing the previous average price target of $9.00, the current average has increased by 19.44%.
Interpreting Analyst Ratings: A Closer Look
The standing of Metagenomi among financial experts is revealed through an in-depth exploration of...
Login or create a forever free account to read this news
Sign up/Log in
